Clinical trial
CareSuperb COVID-19 Antigen Home Test Usability Study
NCT05629455 is registered in ClinicalTrials.gov with AccessBio, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CareSuperb COVID-19 Antigen Home Test Usability Study
- Lead sponsor
- AccessBio, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 17, 2022
- Completion date
- November 22, 2022
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.